I believe JD and anything to do with Crispr like EDIT and NTLA stand a good chance at being such opportunities... I am holding all 3 for the long term.
Thanks for the great tip, and I will initiate the HW. It is not the sector/ind I am huge fan of anymore (pharma/biotech), but definitely would love to start the heavily beat up (distressed) or ones with good potentials.
Thanks for the great tip, and I will initiate the HW. It is not the sector/ind I am huge fan of anymore (pharma/biotech), but definitely would love to start the heavily beat up (distressed) or ones with good potentials.
My pleasure. For those who don’t know, JD.com is currently the little brother to Alibaba (the Amazon of China), but JD has taken a lot of strategic moves the last year or so, which could help it overtake BABA in a number of ways over time.